Not All Healthy Donors Mobilize Hematopoietic Progenitor Cells Sufficiently After G-CSF Administration to Allow for Subsequent CD34 Purification of the Leukapheresis Product
- 1 April 1998
- journal article
- Published by Mary Ann Liebert Inc in Journal of Hematotherapy
- Vol. 7 (2) , 111-113
- https://doi.org/10.1089/scd.1.1998.7.111
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Stem Cell Mobilization in Normal DonorsJournal of Hematotherapy, 1997
- Composition of peripheral blood progenitor cell components collected from healthy donorsTransfusion, 1997
- Re: Toward a Worldwide Standard for CD34+ EnumerationJournal of Hematotherapy, 1997
- Daily Measurements of Blood CD34+ Cells After Stem Cell Mobilization Predict Stem Cell Yield and Posttransplant Hematopoietic RecoveryJournal of Hematotherapy, 1997
- The Use of Mobilized Peripheral Blood Stem Cells from Normal Donors for AllograftingThe International Journal of Cell Cloning, 1997
- STEM CELL MOBILIzATION IN NORMAL DONORS FOR ALLOGENEIC TRANSPLANTATION: ANALYSIS OF SAFETY AND FACTORS AFFECTING EFFICACYBritish Journal of Haematology, 1996
- THE PLACE OF BLOOD STEM CELLS IN ALLOGENEIC TRANSPLANTATIONBritish Journal of Haematology, 1996
- Optimizing dose and scheduling of filgrastim (granulocyte colony- stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers [see comments]Blood, 1995
- G‐CSF‐mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graftBritish Journal of Haematology, 1994